Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Neuroscience|August 27, 2019
Increased Ethanol Consumption and Locomotion Develop upon Ethanol Deprivation in Rats Overexpressing the Adenosine (A)<sub>2A</sub> ReceptorMagdalena Zaniewska, Dawid Gawliński, Maria Wyczesana, et al.
International Journal of Molecular Sciences|December 17, 2014
Expression of the MT1 melatonin receptor in ovarian cancer cellsKarolina Jablonska, Bartosz Pula, Agata Zemla, et al.
Biomedicines|October 23, 2021
Phoenixin as a New Target in the Development of Strategies for Endometriosis Diagnosis and TreatmentKarolina Iwona Kulinska, Mirosław Andrusiewicz, Anna Dera-Szymanowska, et al.
International Journal of Molecular Sciences|October 14, 2023
Serum Proteomic Profiles of Patients with High and Low Risk of Endometrial Cancer RecurrenceDagmara Pietkiewicz, Mikołaj Piotr Zaborowski, Kamila Jaz, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 19, 2012
Enhanced immunoreactivity of TIMP-2 in the stromal compartment of tumor as a marker of favorable prognosis in ovarian cancer patientsAgnieszka Hałoń, Ewa Nowak-Markwitz, Piotr Donizy, et al.
Cancer Immunology, Immunotherapy : CII|November 2, 2020
Granzyme B in peripheral blood mononuclear cells as a measure of cell-mediated immune response in paraneoplastic neurological syndromes and malignancyMikołaj Piotr Zaborowski, Patrycja Stefens-Stawna, Krystyna Osztynowicz, et al.
Anticancer Research|December 11, 2013
Comparison of minichromosome maintenance proteins (MCM-3, MCM-7) and metallothioneins (MT-I/II, MT-III) expression in relation to clinicopathological data in ovarian cancerChristopher Kobierzycki, Bartosz Pula, Mateusz Skiba, et al.
Pathology Oncology Research : POR|January 6, 2011
Estrogen receptor alpha expression in ovarian cancer predicts longer overall survivalAgnieszka Halon, Verena Materna, Malgorzata Drag-Zalesinska, et al.
Anticancer Research|March 8, 2011
Loss of estrogen receptor beta expression correlates with shorter overall survival and lack of clinical response to chemotherapy in ovarian cancer patientsAgnieszka Halon, Ewa Nowak-Markwitz, Adam Maciejczyk, et al.
Histology and Histopathology|February 20, 2008
Decreased expression of p16 in ovarian cancers represents an unfavourable prognostic factorPawel Surowiak, Verena Materna, Adam Maciejczyk, et al.
Pageof 14